Comments from Craig Cochran – Managing Director, Founder, Medcan Australia:

Medcan Australia Founder and CEO, Craig Cochran said: “Medcan Australia are very excited to be a part of the CMOS study. Studies like CMOS are extremely important to build credible data around medicinal cannabis products and patient responses for various indications. As a leader in the Australian medicinal cannabis industry, Medcan Australia is proud to support the advancement of medicinal cannabis research both locally and internationally”

Background

Medcan Australia was founded in 2016 and was one of the first Australian companies to be licensed by the Office of Drug Control (ODC) to cultivate and produce Medicinal Cannabis, manufacture Medicinal Cannabis products and import and export Medicinal Cannabis products.  The company was founded with a single vision to provide Australian patients with high quality, fair priced Medicinal Cannabis products.

Medcan have a dedicated Cultivation, Production, Manufacture and Pharmaceutical wholesaling facility located in Brisbane Australia.  Medcan currently import a range of TGO93 compliant MEDCAN branded products for supply to Australian patients.

For Further Information please contact:

Gareth Ball

+61414860512

1800 633 226
Po Box 4579, Springfield, QLD, Australia, 4300

gareth@medcanaustralia.com.au

www.medcanaustralia.com.au

stethoscope

Patient’s
Advocacy

Medical Cannabis

Medical
Cannabis

Medical Cannabis

Cannabis
Awareness

Advanced Treatments

Advanced
Treatments